Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-viral Anosmia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 0 results

Large-scale testing (Phase 3)Study completedNCT04830943
What this trial is testing

Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia

Who this might be right for
Covid19 Related Anosmia and Aguesia
Assiut University 250
Not applicableUnknownNCT04598763
What this trial is testing

Evaluation of Two Methods of Olfactory Rehabilitation in Post-viral Loss of Smell: Classic and Intensive

Who this might be right for
Olfaction Disorders
Central Hospital, Nancy, France 80
Large-scale testing (Phase 3)UnknownNCT06055270
What this trial is testing

Stellate Ganglion Block With Lidocaine for the Treatment of COVID-19-Induced Parosmia

Who this might be right for
Parosmia
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 44
Testing effectiveness (Phase 2)Study completedNCT03990766
What this trial is testing

Smell Changes & Efficacy of Nasal Theophylline

Who this might be right for
Olfactory DisorderAnosmiaViral Infection+2 more
Washington University School of Medicine 27
Large-scale testing (Phase 3)Looking for participantsNCT05855369
What this trial is testing

Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)

Who this might be right for
Smell DysfunctionOlfactory DisorderLong COVID
Medical University of South Carolina 145
Testing effectiveness (Phase 2)Study completedNCT06253806
What this trial is testing

Stellate Ganglion Block for COVID-induced Parosmia

Who this might be right for
COVID-19-Induced Parosmia
Washington University School of Medicine 48